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Abstract The purpose of this study was to demonstrate
feasibility of percutaneous transluminal aortic stenting and
cava filter placement under magnetic resonance imaging
(MRI) guidance exclusively using a polyetheretherketone
(PEEK)-based MRI-compatible guidewire. Percutaneous
transluminal aortic stenting and cava filter placement were
performed in 3 domestic swine. Procedures were performed
under MRI-guidance in an open-bore 1.5-T scanner. The
applied 0.035-inch guidewire has a PEEK core reinforced by
fibres, floppy tip, hydrophilic coating, and paramagnetic
markings for passive visualization. Through an 11F sheath, the
guidewire was advanced into the abdominal (swine 1) or
thoracic aorta (swine 2), and the stents were deployed. The
guidewire was advanced into the inferior vena cava (swine 3),
and the cava filter was deployed. Postmortem autopsy was
performed. Procedural success, guidewire visibility, pushabil-
ity, and stent support were qualitatively assessed by consensus.
Procedure times were documented. Guidewire guidance into
the abdominal and thoracic aortas and the inferior vena cava
was successful. Stent deployments were successful in the
abdominal (swine 1) and thoracic (swine 2) segments of the
descending aorta. Cava filter positioning and deployment was
successful. Autopsy documented good stent and filter posi-
tioning. Guidewire visibility through applied markers was rated
acceptable for aortic stenting and good for venous filter
placement. Steerability, pushability, and device support were
good. The PEEK-based guidewire allows either percutaneous
MRI-guided aortic stenting in the thoracic and abdominal
segments of the descending aorta and filter placement in the
inferior vena cava with acceptable to good device visibility and
offers good steerability, pushability, and device support.
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Introduction
Magnetic resonance imaging (MRI) provides excellent soft-
tissue contrast and allows image acquisition and three-
dimensional reconstruction in any orientation. Compared with
fluoroscopy, which is currently used for endovascular inter-
ventions, it lacks radiation exposure to the patient and staff and
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may be used without nephrotoxic contrast media. MRI’s
known ability to depict and/or quantify functional parameters
(e.g., blood flow, diffusion, perfusion, etc.) may be used to
determine the success of an endovascular intervention [1, 2].
However, there have only been some reports on MRI-
guided endovascular intervention in the literature [1–5].
With modern open-bore MR-systems and fast sequences
being available as well as MR-compatible stents, angio-
plasty balloons and non-braided catheters on the market,
this has by most authors been attributed to the lack of an
MR-compatible guidewire [6].
In some animal studies, taking the risk of rapid in vivo
heating and spark yielding into account, standard nitinol
guidewires were used. Sometimes the entire procedure was
performed without using a guidewire for device delivery
[6–10].
A concept of a MRI-compatible guidewire with a PEEK
core was published, but until today the in vivo applicability
of such passively marked PEEK-based guidewires has not
been proven [11].
The purpose of this study was to show the first in vivo
use of an MRI-compatible 0.035-inch PEEK-based guide-
wire for MRI-guided thoracic and abdominal aortic
stenting and cava filter placement in swine.
Materials and Methods
PEEK-Based Guidewire
A 0.035-inch, 160 cm–long MRI-compatible guidewire was
used (Biotronik Vascular Intervention, Buelach, Switzer-
land). It has a central PEEK core (0.57-mm diameter)
reinforced by fibres. This core compound is tapered (to
0.15 mm in diameter) at the distal 12 cm, thereby providing
an atraumatic tip. The guidewire core is covered along its
axis with a polyurethane jacket and a hydrophilic coating.
It provides passive MRI markings composed of
paramagnetic alfa–Fe3O4 nanoparticles (MagnaFy; Magna-
Medics GmbH, Aachen, Germany) (Fig. 1). These nano-
particles were applied on the wire in an adhesive coating,
forming 0.03-mm thick and 1.5-mm broad markings. For
aortic stenting, four distal markings were spaced by 20 mm.
Two further markings were separated by 40 mm, enhancing
visibility of the distal part of the guidewire shaft. For cava
filter placement, 7 markers were attached, with the distal 5
markers being separated by 20 mm.
MR Imaging and MR Suite
A 1.5-T whole-body open-bore scanner (Espree; Siemens
Healthcare, Erlangen, Germany) was used. With a
high-performance gradient system (gradient strength 33 mT/
m; slew rate 100 T/m/s) and standard surface receiver coils, a
gradient echo T1-FLASH sequence (BEAT-IRT) was used.
Imaging parameters were as follows: field of view 400 9
358 mm; matrix size 288 9 172; voxel size 2.3 9 1.4 9
5.0 mm; TR 8.12 ms; TE 5.24 ms; flip angle 218; bandwidth
299 Hz/pixel. Images were displayed on an 18-inch monitor
(Siemens Healthcare, Erlangen, Germany) mounted beside
the MRI-scanner (frame rate 2/3 per second).
Before the intervention, a single intravenous injection of
blood-pool contrast media gadofosveset (Vasovist; Ba-
yerSchering Pharma, Berlin, Germany) in a dosage of
0.03 mmol gadolinium (Gd)/kg body weight (bw) was
administered to achieve better vascular depiction
throughout the remainder of the procedures.
Animal Preparation
Animal experiments were conducted at the University
Hospital Essen (Germany) according to the policies for the
human care and use of animals. The procedures performed
were approved by the Regional and Institutional Animal
Care and Use Committee.
Three domestic pigs (60–70 kg bw) were prepared
according to a previously published protocol [12]. Pigs
were intubated using an 6.5-mm endotracheal tube and
ventilation which was performed throughout the procedure
by a respirator (Oxylog; Dra¨ger, Lu¨beck, Germany). Dur-
ing the entire procedure, infusion anaesthesia was
maintained by continuous administration of propofol,
midazolam, and fentanyl.
After surgical preparation, 11F/10-cm catheter sheaths
(Radiofocus Introducer II; Terumo, Leuwen, Belgium)
were inserted in the iliac arteries and in the iliac vein. A
heparin bolus (5,000 U) was given intravenously after
sheath placement, and 1,000 U were given every hour
consecutively. Animals were then placed supine and head
first into the MRI scanner.
Fig. 1 Photograph of the distal portion of the 0.035-inch PEEK-
based MRI-compatible guidewire used in our study. This 0.035-inch
guidewire has a soft tip and a hydrophilic coating. For aortic stenting,
6 markers were applied to the wire. The distal 4 passive MRI
markings are separated by 20 mm, and 2 markings further proximal
are separated by 40 mm
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MRI Intervention
Aortic stent placement and cava filter placement were
performed by experienced interventional radiologists in all
swine through the iliac catheter sheath and using MRI
guidance as previously described.
Abdominal Aortic Stenting: Swine 1
Through the 11F vascular access sheath, the guidewire was
advanced into the suprarenal segment of the descending
aorta. Over the guidewire, a balloon (Pheron 10 mm/
40 mm; Biotronik) was placed in the infrarenal abdominal
aorta, followed by percutaneous transluminal angioplasty
(PTA) through inflation of the balloon with 1–2 ml
(0.025 mmol/l) Gd-DOTA (Dotarem; Guerbet, Roissy
CDG Cedex, France). Thereafter, a self-expandable stent
was positioned in the infrarenal abdominal aorta and
deployed (Astron 10 mm/60 mm). A second balloon dila-
tation was performed within the stent (Pheron 10 mm/
40 mm; Biotronik).
Thoracic Aortic Stenting: Swine 2
Through the left 11 vascular access sheath, the guidewire
was advanced into the thoracic segment of the descending
Fig. 2 Abdominal aortic stenting. (A) The right renal artery is
marked by a stent implanted earlier (arrow). The guidewire is
introduced (A, arrowhead) and advanced into the suprarenal aortic
segment (B, arrow). (C) The balloon is inserted over the wire but is
poorly visible through slight artefacts caused by the commercially
attached standard markers (arrow). (D) The balloon is inflated with
1–2 ml (0.025 mmol/l) Gd-DOTA (Dotarem) (arrow). (F through H)
The balloon is replaced by the self-expandable stent (E, arrowheads),
and the stent is sequentially deployed (arrowheads). (J) The balloon
is placed in the stent (arrowhead), and dilatation (J, arrowhead) is
performed within the stent. Balloon and guidewire are removed (K,
arrowhead), and the stent position is documented (L, arrowhead)
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aorta. Over the guidewire, the self-expandable stent
(Wallstent 22 mm/45 mm; Boston Scientific, Maple
Grove, MN) was positioned in the descending thoracic
aorta beyond the origin of the left subclavian artery and
released.
Cava Filter Placement: Swine 3
Through the venous iliac 11F access sheath, the guidewire
was advanced 2 times into the hepatic segment of the
inferior vena cava. Over the positioned guidewire, the
Fig. 3 Thoracic aortic stenting. The guide PEEK-based guidewire (A through C, arrowheads) is advanced into the descending thoracic segment
of the aorta (A). The stent (arrow) is advanced over the wire (B), positioned, and released (C, arrow)
Fig. 4 Photographs of autopsy
documentation. A Stent in the
right renal artery (arrow). The
infrarenal abdominal aortic stent
(A, arrowhead) and the stent in
the descending thoracic aortic
segment (B, arrowhead) are
marked. An incision in the
proximal descending aortic
segment exposed the proximal
end of the thoracic stent. After
preparation of the liver and
partial exposition of the inferior
vena cava, the inferior vena
cava filter can be seen (C,
arrow). Longitudinal incision of
the ventral wall of the inferior
vena cava demonstrates the
good positioning and full and
correct deployment of the
placed cava filter (D, arrow)
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filter’s 6F (internal diameter), 90 cm-long introducer
sheath OptEase; Retrievable Vena Cava Filter; Cordis
Europe, Roden, The Netherlands) was advanced into
inferior vena cava. Because of the atypically deep retro-
peritoneal position of the right kidney, the infrarenal
segment of the inferior vena cava was short and did not
allow filter placement below the renal veins. The sheath,
which was marked only by a regular X-ray–absorbing
marker at the tip, was therefore positioned twice in the
hepatic segment of the inferior vena cava. Correct intra-
venous positioning of the sheath was documented by hand
injection of a 10-ml bolus (0.05 mmol Gd/ml) Gd-DOTA
(Dotarem). The guidewire was withdrawn and the self-
centering 6 diamond–shaped cava filter (Optease Retriev-
able Vena Cava Filter; Cordis Europe, Roden, The
Netherlands) positioned and released in the hepatic seg-
ment of the inferior vena cava.
Procedure times were documented for the interventions
in all swine. Success rates (2 grades: ±) of any procedure
step were rated, and guidewire characteristics—such as
visibility, pushability, steerability, and filter/balloon/stent
support (3 grades: poor [?]; acceptable [??]; and good
[???])—were assessed by consensus among the inter-
ventional radiologists.
After the experiments, the swine were killed by intra-
venous injection of phenobarbital (80 mg/kg). The
positions of the deployed stents and the cava filter were
documented by postmortem autopsy.
Results
Aortic Stenting
Guidewire guidance into the targeted abdominal and tho-
racic aortic segments was successful (2 of 2). Over-the-wire
placement and dilatation of the PTA balloon in the
abdominal aorta was feasible before and after stent
deployment (2 of 2). Over-the-wire positioning and release
of self-expandable stents was successful (2 of 2) (Figs. 2, 3).
Postmortem autopsy showed good stent positioning and no
evidence of traumatic vessel wall damage (Fig. 4). Proce-
dure times were 12 minutes for stenting of the thoracic aortic
segment and 10 minutes for stenting of the abdominal aortic
segment. The guidewire, its surface, and the applied passive
marking macroscopically remained intact. There was no
evidence of guidewire fracture or kinking. By consensus,
guidewire visibility was rated acceptable (??) and guide-
wire pushability, steerability, and balloon/stent support
were rated good (???).
Cava Filter Placement
Guidewire positioning in the hepatic segment of the inferior
vena cava was successful as was placement of the cava filter’s
introducer sheath over the wire (Figs. 5, 6). After removal of
the guidewire, positioning and release of the filter through the
introducer sheath was successful. Postmortem autopsy
showed good filter positioning in the hepatic segment of the
inferior vena cava (Fig. 4). Autopsy showed no evidence of
traumatic vessel wall damage. Procedure times was 6 min-
utes. The PEEK-based guidewire and its passive markings
remained intact, without macroscopic evidence of guidewire
fracture or kinking. By consensus, guidewire visibility was
rated good (???) and guidewire pushability and introducer
sheath support were rated good (???).
Discussion
This results of this study demonstrate that MRI-guided
stenting of the aorta and cava filter placement are feasible
when using an MRI-compatible PEEK-based guidewire.
Commercially available nonbraided catheters, PTA bal-
loons, and stents may safely be used for MRI-guided
endovascular interventions as shown earlier in different
vascular territories. The first MRI-guided placement of a
vena cava filter, which required 30 seconds for the acquisi-
tion of a single imaging slice, was described in 1997 [13].
With faster sequences available today, 2 more recent studies
Fig. 5 First phlebographic use of the guidewire (coronal view). (A
through C) Under real-time MRI-guidance with FLASH sequence, the
wire is sequentially advanced in the inferior vena cava. First, the two
most distal markers are depicted (A, arrowhead). The guidewire is
advanced into the hepatic segment of the inferior vena cava so that
first the distal 5 markers (B, arrowhead) are visualized, and then all
seven markers are in the field of view (C, arrowheads)
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showed the feasibility cava filter placement in swine under
real-time MRI-guidance [14, 15]. However, given the pre-
viously described advantages of MRI for the guidance of
endovascular procedures, until today this promising tech-
nique has not been shown to be transferable to humans.
This can be explained, as such animal studies did not use
a guidewire for procedure guidance, thereby increasing the
risk to cause vessel dissection, perforation or rupture, or as
a major drawback, observed sparking and guidewire heat-
ing in the magnetic field, when using standard nitinol
guidewires. This crucial limitation, potentially harmful for
the patient and the operator, may now be overcome by the
use of the PEEK-based MR-compatible guidewire. The
guidewire’s mechanical properties, such as its good device
Fig. 6 MR-guided placement of the inferior vena cava filter. (A, B)
The guidewire is sequentially advanced into the hepatic segment of
the inferior vena cava so that all 7 MRI markings are in the field of
view (arrowheads). (C, D) The unmodified 6F filter introducer sheath
is advanced over the wire into the hepatic segment of the vein
(arrowhead). (E) The standard X-ray-absorbing marker of the sheath
(arrow) only causes a weak artefact in the magnetic field. (D) After
guidewire removal, correct intravenous sheath positioning is docu-
mented applying a contrast media flush through the introducer sheath
(arrow). (E) The guidewire is the reinserted (arrowhead) through the
introducer sheath (E, arrow). (F) The sheath is advanced more
centrally (arrow), and the wire is removed. (G through I) With the
sheath in place, the filter is then pushed into and through the sheath
(arrowheads). (J) After full deployment of the filter, the introducer
sheath (arrowhead) is removed (K). (L) Axial images of the hepatic
segment of the inferior vena cava document full deployment of the
filter, and 6 straight filter struts are depicted in the periphery of the
vein (arrowhead)
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support capabilities and pushability, are promising, and the
floppy wire tip allows atraumatic procedure guidance. The
attached paramagnetic markings provide at least acceptable
device visibility in gradient-echo sequences. This passive-
marker approach allows simple handling of the guidewire
and leads to short procedure time. This is beneficial,
compared with other more complicated active-tracking
approaches (e.g., guidewire receiver coils) applied earlier
[16–20]. The first concepts of automated tracking for pas-
sively marked devices have been investigated and may
facilitate procedures in the future [21]. Modification of the
passive marking’s size and thickness may optimize vessel–
lumen contrast and allow marker use according to the
diameter of the targeted vessel. The commercially avail-
able stents and balloons used in our study were chosen
according to target vessel size and product availability.
The OptEase cava filter used in our study is known to be
safely usable in the magnetic field [22]. In this study, the
filter and its introducer sheath were applied as commer-
cially available without additional MRI markings. This
lead to suboptimal visibility of the sheath, through a weak
artefact caused by the X-ray–absorbing marker at its tip.
For suboptimal visibility of the introducer sheath, sheath
positioning was verified in this study through the marker
and additional free-hand bolus contrast-media injection
through the sheath. Thereby the introducer sheath was
safely introduced and precisely positioned over the wire.
Because of the atypical deep inflow of the right renal vein
in our swine, suprarenal filter placement was performed in
the inferior vena cava, which has been shown to be safe
and effective in humans [23].
In the future, application of the described passive
markings to balloons, stents, filters, introducer sheaths,
and catheters (if needed) may facilitate depiction of such
over-the-wire devices for MRI-guided endovascular
procedures.
Intravenous application of blood-pool contrast media
provides good vascular depiction throughout the interven-
tions. Its higher relaxivity and longer blood half-life
(average distribution phase 0.48 hours) compared with
standard extracellular MRI contrast medias, may allow
endovascular procedure control with a single injection of
contrast media in the future [23–25].
Acknowledgments This study was designed as a first-proof concept
study in swine. Of course, further investigation is necessary to
determine the potential of this new PEEK-based guidewire for MRI-
guided arterial and venous interventions.
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